explore -WSS

explore

author：entertainment 2025-10-01 11:36:38 - browse：6

Are venture capitalists OK? Are bolt-ons good for business? And when is it safe to say someone overpaid?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how biotech’s downturn has made life difficult not just for startups but also the VCs they rely on for much-needed funding. We also take a look at Gilead Sciences’ struggle to turn itself into an oncology company and the latest biotech to get bought out by a major pharma firm.

For more on what we cover, here’s more on Gilead; here’s the news on Inhibrx; here’s the latest on biotech venture capital; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Why patients can’t get everything they want on drug pricing

WSS

Democrats decry new health bill for going easy on private equity

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

The haunting brain science of long Covid

The haunting brain science of long Covid

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Intellia reports positive results for its CRISPR

focus

explore

explore

United colonoscopy coverage change 'may cost lives,' doctors say

Let's speed up science by embracing open access publishing

Sports medicine is finally prioritizing gender equality

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Virginia high school admissions case could be legal follow

'Investigate these claims': UFO transparency at center of House hearing

How to save PrEP access — and even expand it

HIV drugs protect against transmission, even in unprotected sex

Moonlake's readout produced a cash windfall. Risks remain

UHS says company favors patients whose insurance pays more

knowledge

Rise in cancer among younger people worries and puzzles doctors

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

ASCO: Palliative care found as helpful given virtually as in person

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Roche’s Alnylam deal shows drug firms interested in heart drugs

The haunting brain science of long Covid

entertainment

knowledge

leisure time

explore